期刊
CURRENT PHARMACEUTICAL DESIGN
卷 12, 期 28, 页码 3631-3644出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161206778522065
关键词
arrhythmia; hERG; I-Kr; I-Kr; KCNE; KCNQ1; Kv1.5; MinK; MiR1
资金
- NHLBI NIH HHS [R01 HL079275] Funding Source: Medline
- NIDCD NIH HHS [R03 DC07060] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007060] Funding Source: NIH RePORTER
Potassium channels form highly K+ ion-selective pores in the plasma membrane of excitable cells. Voltage-gated potassium (Kv) channels open in response to membrane depolarization to allow rapid diffusion of K+ ions out of the cell, thus repolarizing the cell to restore a negative resting membrane potential. Inherited mutations in Kv channel genes produce abnormal cellular repolarization and cause diseases of excitable tissues. Small molecule interactions with Kv channels can cause similar pathologies. During the last decade of research into Kv channels and associated diseases termed 'channelopathies' - we have begun to understand Kv channel function and dysfunction at the molecular level. In this review, the molecular mechanisms of Kv channelopathies are discussed, with particular emphasis on the overlap between inherited and acquired disease, and the drive towards novel channel-targeted therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据